Decitabine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5763 publications
A survival prognostic model for high-risk myelodysplastic syndrome patients treated with decitabine.
A survival prognostic model for high-risk myelodysplastic syndrome patients treated with decitabine.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 13, 2026
Rewiring Metal-Dependent Cell Death to Unlock Immunotherapy in Colorectal Cancer.
Journal: Nano letters
Published: April 06, 2026
HSR26-237: Meta-Analysis Confirms Venetoclax Plus Decitabine as a Frontline Game-Changer in Elderly AML (Acute Myeloid Leukemia).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 31, 2026
Corrigendum to "Recurrent Transcriptional Responses in AML and MDS patients Treated with Decitabine" Experimental Hematology. 2022;111:50-65.
Journal: Experimental hematology
Published: March 29, 2026
Enhanced Remission and Survival Outcomes with Decitabine Plus Venetoclax in Additional Sex Comb Like 1 Mutated Acute Myeloid Leukemia.
Journal: Journal of visualized experiments : JoVE
Published: March 23, 2026
DNA Hypermethylation Suppresses Thyroid Peroxidase Expression and May Be a Promising Diagnostic Marker for Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: March 04, 2026
DNA methyltransferase inhibitors in oncology: clinical progress, limitations and future directions.
Journal: Epigenomics
Published: February 28, 2026
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancer.
Journal: mBio
Published: February 10, 2026
Epigenetic editing of marine medaka ( Oryzias melastigma) fgf2 using CRISPR/dCas9-Tet1CD.
Journal: Zoological research
Published: February 03, 2026
Composite nanovesicles for enhanced chemodynamic cancer therapy via decitabine-mediated epigenetic reactivation.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 26, 2026
Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.
Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.
Journal: Acta haematologica
Published: January 21, 2026
Last Updated: 04/28/2026